Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

vertex-headquarters

Vertex cystic fibrosis drugs become available in Scotland after NHS rejection

September 12, 2019 Sales and Marketing SMC, Vertex, cystic fibrosis

Two potentially life-changing cystic fibrosis drugs are to become available for a potential pool of 400 patients in Scotland just …
News
pharmafocus_sept_2019_cover

Read the September edition of Pharmafocus online now!

September 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …
News
stephen_stamp

Former Ergomed CEO appointed as Midatech’s Chief Financial Officer

September 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ergomed, midatech

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be …
Appointment

GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease

September 11, 2019 Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease

Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …
News
tony-coles_0

Tony Coles appointed to Pfizer Spinout Cerevel as CEO

September 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerevel, Pfizer, pharma

Cerevel Therapeutics, a pharmaceutical company dedicated to treating neurological diseases, has appointed renowned biotechnology leader Tony Coles as Chief Executive …
Appointment
gary_gordon

Ayala hires AbbVie’s Gary Gordon as new CMO

September 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Ayala

AbbVie’s former Vice President of Oncology has moved to Ayala Pharmaceuticals to work as its new Chief Medical Officer (CMO).  …
Appointment
merck-keytruda

MSD’s Keytruda approved for first-line lung cancer use on NHS Scotland

September 10, 2019 Manufacturing and Production, Sales and Marketing Cancer, MSD, SMC, Scotland, keytruda, lung cancer, pharma

MSD and lung cancer patients will be celebrating the news that the pharma giant’s immunotherapy Keytruda (pembrolizumab) has been accepted …
News
boehringer_biberach_germany_copy

Boehringer’s Ofev scores first-of-its-kind FDA approval in rare lung disease

September 10, 2019 Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, FDA, US, lungs, ofev, pharma, rare disease

Boehringer Ingelheim’s Ofev (nintedanib) capsules have now secured marketing authorisation in the US, it has emerged, for the treatment of …
News

Axon seeks global partner after positive Phase 2 data for Alzheimer’s vaccine

September 10, 2019 Manufacturing and Production, Sales and Marketing Alzheimer's, Alzheimers, Axon

Axon Neuroscience has announced data from its Phase 2 trial ADAMANT for the first-in-class vaccine AADvac1 to slow the progression …
News

Novo Nordisk set to launch price cut for insulin drug NovoLog after harsh criticism over prices in the US

September 9, 2019 Sales and Marketing Novo Nordisk, NovoLog, insulin

Danish drug maker Novo Nordisk has said it will offer a generic version of NovoLog (insulin aspart) at a price …
News
lilly_entrance_web

Lilly’s LOXO-292 shrinks tumours in lung cancer trial

September 9, 2019 Research and Development, Sales and Marketing Cancer, Eli Lilly, lung cancer, pharma

Eli Lilly has announced its experimental cancer drug LOXO-292, acquired in January, shrank tumours in almost 70% of advanced lung …
News
shutterstock

Age affects efficacy of immunotherapy treatments in breast cancer patients

September 9, 2019 Research and Development, Sales and Marketing Cancer, breast cancer, pharma

Recent clinical trial data has shown that immune checkpoints blockade (ICB) therapy, designed to unleash a patient’s immune system to …
News
trump-fda

Trump’s FDA: Is the US regulator being steered by the President?

September 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, US, drug safety, pharma

FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a …
Feature
novartis_side_building

4.5-year data confirms long-term efficacy of Novartis’ Aimovig in episodic migraine

September 9, 2019 Research and Development, Sales and Marketing Aimovig, Novartis, migraine, pharma

Novartis has lifted the curtain on interim data from the 4.5-year mark of a five-year open-label treatment period (OLTP) investigating …
News

AstraZeneca’s Imfinzi combo tops chemotherapy in treatment-naive advanced lung cancer

September 9, 2019 Sales and Marketing AstraZeneca, Cancer, Imfinzi, lung cancer, pharma

AstraZeneca has unveiled new Phase 3 data for its immunotherapy Imfinzi (durvalumab), showing that it achieved its primary endpoint when …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026